OXFORD, England, July 5, 2023 /PRNewswire/ -- Ultromics, a leading health technology company advancing a novel approach for detecting heart failure and its phenotypes, announced today the assignment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results